Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKYA

Akoya Biosciences (AKYA) Stock Price, News & Analysis

Akoya Biosciences logo

About Akoya Biosciences Stock (NASDAQ:AKYA)

Advanced Chart

Key Stats

Today's Range
$1.29
$1.29
50-Day Range
$1.12
$1.37
52-Week Range
$0.93
$3.42
Volume
N/A
Average Volume
416,191 shs
Market Capitalization
$64.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.38
Consensus Rating
Hold

Company Overview

Receive AKYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AKYA Stock News Headlines

AKYA Akoya Biosciences, Inc. - Seeking Alpha
How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
See More Headlines

AKYA Stock Analysis - Frequently Asked Questions

Akoya Biosciences, Inc. (NASDAQ:AKYA) released its quarterly earnings results on Monday, May, 12th. The company reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.03. The firm had revenue of $16.64 million for the quarter, compared to analyst estimates of $20.19 million. Akoya Biosciences had a negative trailing twelve-month return on equity of 487.85% and a negative net margin of 59.44%.

Akoya Biosciences (AKYA) raised $125 million in an IPO on Friday, April 16th 2021. The company issued 6,600,000 shares at a price of $18.00-$20.00 per share. J.P. Morgan, Morgan Stanley, Piper Sandler and Canaccord Genuity served as the underwriters for the IPO.

Top institutional shareholders of Akoya Biosciences include Geode Capital Management LLC (0.49%), JPMorgan Chase & Co. (0.28%), JBF Capital Inc. (0.24%) and Marshall Wace LLP (0.15%). Insiders that own company stock include Matthew Winkler, Garry PhD Nolan, Brian Mckelligon, John Frederick Ek, Frederic Pla and Joseph Driscoll.
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akoya Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Broadcom (AVGO), Invesco QQQ (QQQ) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/12/2025
Today
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:AKYA
CIK
1711933
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.08
Potential Upside/Downside
+84.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.37 million
Net Margins
-59.44%
Pretax Margin
-59.28%
Return on Equity
-487.85%
Return on Assets
-35.86%

Debt

Debt-to-Equity Ratio
10.12
Current Ratio
0.61
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$79.96 million
Price / Sales
0.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.15 per share
Price / Book
8.60

Miscellaneous

Outstanding Shares
49,954,000
Free Float
46,307,000
Market Cap
$64.44 million
Optionable
Optionable
Beta
1.36
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:AKYA) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners